• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. RIVAL PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. RIVAL PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number RV135415
Medical Device Problem Codes Leak/Splash (1354); Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/23/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiry date: 11/2023).
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon allegedly ruptured at 10 atm.The procedure was completed using another device.There was no reported patient injury.
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon allegedly ruptured at 10 atm and the contrast agent leaked from the balloon.The procedure was completed using another device.There was no reported patient injury.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.A definitive root cause for the reported balloon rupture and leak could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: b5, d4 (expiry date: 11/2023), g3, h6 (device) h11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one rival pta dilatation catheter has been received for the evaluation.On the visual evaluation, the device was noted to be bloody.No kinks noted to the catheter shaft, no anomalies to the luers and y-body.On the functional evaluation, the balloon was inflated using an inhouse presto inflation device.Then the water starts leaking from the ruptured region of the balloon.Under the microscopic observation, the pinhole rupture was noted on the balloon.No other functional testing performed.Therefore the investigation for the reported balloon rupture was confirmed as the pinhole rupture was noted under the microscopic observation.The investigation for the reported leak was also confirmed as the water starts leaking from the ruptured region of the balloon upon inflation.A definitive root cause for the reported balloon rupture and leak could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 11/2023).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon allegedly ruptured at 10 atm and the contrast agent leaked from the balloon.It was further reported that the procedure was completed using another device.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RIVAL PTA DILATATION CATHETER
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key12194467
Report Number2020394-2021-01350
Device Sequence Number11712910
Product Code DQY
UDI-Device Identifier00801741063435
UDI-Public(01)00801741063435
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K120722
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberRV135415
Device Catalogue NumberRV135415
Device Lot NumberGFEY1918
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/10/2021
Initial Date Received by Manufacturer 06/23/2021
Supplement Date Received by Manufacturer08/10/2021
09/27/2021
Initial Report FDA Received Date07/20/2021
Supplement Report FDA Received Date08/12/2021
09/29/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age60 YR
-
-